PA Crooks

First name:
PA
Last name:
Crooks
Beckmann, J. S., Meyer, A. C., Pivavarchyk, M., Horton, D. B., Zheng, G., Smith, A. M., et al. (2015). r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research, 40(10), 2121-30. https://doi.org/10.1007/s11064-015-1680-4
View
Lee, N. R., Zheng, G., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2018). New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. The Aaps Journal, 20(2), 29. https://doi.org/10.1208/s12248-018-0192-y (Original work published 2018)
View
Maggio, S. E., Saunders, M. A., Nixon, K., Prendergast, M. A., Zheng, G., Crooks, P. A., et al. (2018). An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI. Drug And Alcohol Dependence, 193, 154-161. https://doi.org/10.1016/j.drugalcdep.2018.09.008 (Original work published 2018)
View
Lee, N. R., Zheng, G., Leggas, M., Crooks, P. A., Bardo, M. T., Dwoskin, L. P., et al. (2019). GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine. The Journal Of Pharmacology And Experimental Therapeutics, 371(2), 526-543. https://doi.org/10.1124/jpet.119.258699
View
Kearney, S. E., Zahoránszky-Kőhalmi, G., Brimacombe, K. R., Henderson, M. J., Lynch, C., Zhao, T., et al. (2018). Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space. Acs Central Science, 4(12), 1727-1741. https://doi.org/10.1021/acscentsci.8b00747 (Original work published 2018)
View
Crooks, P. A., Kottayil, S. G., Al-Ghananeem, A. M., & Butterfield, D. A. (2006). Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners. Bioorganic & Medicinal Chemistry Letters, 16(16), 4291-5. https://doi.org/10.1016/j.bmcl.2006.05.060 (Original work published 2006)
View
Houdi, A. A., Kottayil, S., Crooks, P. A., & Butterfield, D. A. (1996). 3-O-acetylmorphine-6-O-sulfate: a potent, centrally acting morphine derivative. Pharmacology, Biochemistry, And Behavior, 53(3), 665-71. https://doi.org/10.1016/0091-3057(95)02067-5
View
Adejuwon, A., Crooks, P. A., Fadhel-Albayati, Z., Miller, A. F., Zito, S. W., Adeyemi, O. O., & Agbaje, E. O. Antihyperglycemic profile of erinidine isolated from Hunteria umbellata seed. African Journal Of Traditional, Complementary, And Alternative Medicines : Ajtcam, 10(2), 189-202. (Original work published 2013)
View
Dwoskin, L. P., Wooters, T. E., Sumithran, S. P., Siripurapu, K. B., Joyce, B. M., Lockman, P. R., et al. (2008). N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal Of Pharmacology And Experimental Therapeutics, 326(2), 563-76. https://doi.org/10.1124/jpet.108.136630
View
Horton, D. B., Siripurapu, K. B., Norrholm, S. D., Culver, J. P., Hojahmat, M., Beckmann, J. S., et al. (2011). meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release. The Journal Of Pharmacology And Experimental Therapeutics, 336(3), 940-51. https://doi.org/10.1124/jpet.110.175117
View